Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study

Rianne A. Weersink, Katja Taxis, Joost P. H. Drenth, Eline Houben, Herold J. Metselaar, Sander D. Borgsteede

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)
244 Downloads (Pure)


Patients with cirrhosis are at risk for adverse drug reactions (ADRs) due to altered pharmacokinetics and pharmacodynamics. We aimed to determine the prevalence of drug prescriptions and the potential safety of these prescriptions in a real-world cohort of patients with cirrhosis.
Original languageEnglish
Pages (from-to)539-546
JournalDrug Safety
Issue number4
Early online date24-Oct-2018
Publication statusPublished - Apr-2019

Cite this